P
Peng-Yu Yang
Researcher at Scripps Research Institute
Publications - 60
Citations - 3015
Peng-Yu Yang is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Catalysis & Medicine. The author has an hindex of 25, co-authored 50 publications receiving 2197 citations. Previous affiliations of Peng-Yu Yang include Sun Yat-sen University & Scripps Health.
Papers
More filters
Journal ArticleDOI
Highly Enantioselective Iridium-Catalyzed Hydrogenation of Heteroaromatic Compounds, Quinolines
TL;DR: The highly enantioselective hydrogenation of quinoline derivatives is developed using [Ir(COD)Cl]2/(R)-MeO-Biphep/I2 system, and this methodology has been applied to the asymmetric synthesis of three naturally occurring alkaloids angustureine, galipinine, and cuspareine.
Journal ArticleDOI
Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
Zhen Cui,Pan Liu,Nianshuang Wang,Lei Wang,Kaiyue Fan,Qianhui Zhu,Kang-Sheng Wang,Ruihong Chen,Rui Feng,Zijing Jia,Minnan Yang,Ge Xu,Boling Zhu,Wangjun Fu,Tian-jiang Chu,Lei Feng,Yide Wang,Xin-Guo Pei,Peng-Yu Yang,Xiaoliang Sunney Xie,Lei Cao,Yunlong Cao,Xiangxi Wang +22 more
TL;DR: In this article , the structure of the spike (S) from Omicron reveals amino acid substitutions forging interactions that stably maintain an active conformation for receptor recognition, which can be used for the development of broad-spectrum vaccines and therapeutics.
Journal ArticleDOI
Activity-based proteome profiling of potential cellular targets of Orlistat - an FDA-approved drug with anti-tumor activities
TL;DR: This study reports the total of synthesis of THL-like protein-reactive probes, in which extremely conservative modifications were introduced in the parental THL structure to maintain the native biological properties of Orlistat, while providing the necessary functionality for target identification via the bio-orthogonal click chemistry.
Journal ArticleDOI
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
Feng Wang,Dhinakaran Sambandan,Rajkumar Halder,Jianing Wang,Sarah M. Batt,Brian Weinrick,Insha Ahmad,Peng-Yu Yang,Yong Zhang,John Kim,Morad Hassani,Stanislav Huszár,Claudia Trefzer,Zhenkun Ma,Takushi Kaneko,Khisi E. Mdluli,Scott G. Franzblau,Arnab Chatterjee,Kai Johnsson,Katarína Mikušová,Gurdyal S. Besra,Klaus Fütterer,Scott H. Robbins,S. Whitney Barnes,John R. Walker,William R. Jacobs,Peter G. Schultz +26 more
TL;DR: In vitro and in vivo results indicate that this compound functions by a unique mechanism and suggest that TCA1 may lead to the development of a class of antituberculosis agents.
Journal ArticleDOI
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
Kang-Sheng Wang,Zijing Jia,Linilin Bao,Lei Wang,Lei Cao,Hang Chi,Yaling Hu,Qianqian Li,Yunjiao Zhou,Yi-Fan Jiang,Qianhui Zhu,Yong-Qiang Deng,Pan Liu,Nan Wang,Lin Wang,Min Liu,Yurong Li,Boling Zhu,Kaiyue Fan,Wangjun Fu,Peng-Yu Yang,Xin-Guo Pei,Zhen Cui,Lili Qin,Pingju Ge,Jiajing Wu,Shuo Liu,Yi-da Chen,Weijin Huang,Qiao-gang Wang,Cheng-Feng Qin,Youchun Wang,Chuan Qin,Xiangxi Wang +33 more
TL;DR: In this article , the authors examined whether sera from individuals who received two or three doses of inactivated SARS-CoV-2 vaccine could neutralize authentic Omicron.